The Effect of Different Financial Competing Interest Statements on Readers' Perceptions of Clinical Educational Articles
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02548312 |
Recruitment Status :
Completed
First Posted : September 14, 2015
Results First Posted : June 12, 2019
Last Update Posted : June 12, 2019
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Healthy | Other: Variations of financial competing interest statements | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 1065 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double (Participant, Outcomes Assessor) |
Primary Purpose: | Other |
Official Title: | Randomised Controlled Trial to Measure the Effect of Different Financial Competing Interest Statements on Readers' Perceptions of Clinical Educational Articles |
Study Start Date : | January 2016 |
Actual Primary Completion Date : | May 2016 |
Actual Study Completion Date : | May 2016 |
Arm | Intervention/treatment |
---|---|
Experimental: Review 1- competing interest statement 1
Variations of financial competing interest statements. There will be a statement that the authors have no competing interests.
|
Other: Variations of financial competing interest statements
Participants will be randomised to receive 1 of 2 review articles on different topics. For each review there will be 4 groups. Each of the 4 groups will receive an identical version of the review article with the exception of the competing interest statement which will vary depending on group assignment. |
Experimental: Review 1- competing interest statement 2
Variations of financial competing interest statements.
|
Other: Variations of financial competing interest statements
Participants will be randomised to receive 1 of 2 review articles on different topics. For each review there will be 4 groups. Each of the 4 groups will receive an identical version of the review article with the exception of the competing interest statement which will vary depending on group assignment. |
Experimental: Review 1- competing interest statement 3
Variations of financial competing interest statements.
|
Other: Variations of financial competing interest statements
Participants will be randomised to receive 1 of 2 review articles on different topics. For each review there will be 4 groups. Each of the 4 groups will receive an identical version of the review article with the exception of the competing interest statement which will vary depending on group assignment. |
Experimental: Review 1- competing interest statement 4
Variations of financial competing interest statements.
|
Other: Variations of financial competing interest statements
Participants will be randomised to receive 1 of 2 review articles on different topics. For each review there will be 4 groups. Each of the 4 groups will receive an identical version of the review article with the exception of the competing interest statement which will vary depending on group assignment. |
Experimental: Review 2- competing interest statement 1
Variations of financial competing interest statements. There will be a statement that the authors have no competing interests.
|
Other: Variations of financial competing interest statements
Participants will be randomised to receive 1 of 2 review articles on different topics. For each review there will be 4 groups. Each of the 4 groups will receive an identical version of the review article with the exception of the competing interest statement which will vary depending on group assignment. |
Experimental: Review 2- competing interest statement 2
Variations of financial competing interest statements.
|
Other: Variations of financial competing interest statements
Participants will be randomised to receive 1 of 2 review articles on different topics. For each review there will be 4 groups. Each of the 4 groups will receive an identical version of the review article with the exception of the competing interest statement which will vary depending on group assignment. |
Experimental: Review 2- competing interest statement 3
Variations of financial competing interest statements.
|
Other: Variations of financial competing interest statements
Participants will be randomised to receive 1 of 2 review articles on different topics. For each review there will be 4 groups. Each of the 4 groups will receive an identical version of the review article with the exception of the competing interest statement which will vary depending on group assignment. |
Experimental: Review 2- competing interest statement 4
Variations of financial competing interest statements.
|
Other: Variations of financial competing interest statements
Participants will be randomised to receive 1 of 2 review articles on different topics. For each review there will be 4 groups. Each of the 4 groups will receive an identical version of the review article with the exception of the competing interest statement which will vary depending on group assignment. |
- The Readers' Level of Confidence in the Conclusions Drawn in the Article. [ Time Frame: Outcome measure will be assessed only at the time of the intervention (0 weeks). Readers will be asked to complete the study questionnaire immediately after reading the review article. ]Measured on a single-item 10-point Likert scale from (1) "not at all confident" to (10) "extremely confident". Higher scores indicate more confidence. Min score = 0, max score =10.
- Importance of the Article. [ Time Frame: Outcome measure will be assessed only at the time of the intervention (0 weeks) ]
Measured on a single-item 10-point Likert scale from (1) "not at all important" to (10) "extremely important". Higher scores indicate more importance. Min score = 0, max score =10.
Readers will be asked to complete the study questionnaire immediately after reading the review article.
- Interest in the Article. [ Time Frame: Outcome measure will be assessed only at the time of the intervention (0 weeks) ]
Measured on a single-item 10-point Likert scale from (1) "not at all interesting" to (10) "extremely interesting". Higher scores indicate more interest. Min score = 0, max score =10.
Readers will be asked to complete the study questionnaire immediately after reading the review article.
- Number of Participants Who Are Extremely Likely to Change Practice on the Basis of the Article (Scored a "10"), for Those Currently Treating the Relevant Condition [ Time Frame: Outcome measure will be assessed only at the time of the intervention (0 weeks) ]
Measured on a single-item 10-point Likert scale from (1) "not at all likely" to (10) "extremely likely". Higher scores indicate more likely to change practice. Min score = 1, max score =10.
Readers asked to complete the study questionnaire immediately after reading the review article.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Practising doctors in the UK who are members of the British Medical Association (BMA) and receive The BMJ will be included.
Exclusion Criteria:
- BMA members who have opted out of receiving a free copy of The BMJ, public health doctors, consultant oral/dental surgeons, consultants in private practice, retired doctors and student members will be excluded.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02548312
Principal Investigator: | Sara Schroter, PhD | The BMJ |
Responsible Party: | The BMJ |
ClinicalTrials.gov Identifier: | NCT02548312 |
Other Study ID Numbers: |
COI-RCT |
First Posted: | September 14, 2015 Key Record Dates |
Results First Posted: | June 12, 2019 |
Last Update Posted: | June 12, 2019 |
Last Verified: | June 2019 |
Readers' perceptions |